4[1]Prakash A,Markham A.Oral delayed-release mesalazine:a review of its use in ulcerative colitis and Crohn′s disease.Drugs,1999,57(3):383-408
5[2]Sutherland LR,Roth DE,Beck PL.Alternatives to sulfalazine:a meta-analysis of 5-ASA in the treatment of ulcerative colitis.Inflammatory Bowel Dis,1997,34:65-78
6[3]Sutherland L,Roth D,Beck P et al.The use of oral 5-aminosalicylic acid in the induction of remission in ulcerative colitis.In:The Cochrane Library(database on disk and CD-ROM).Oxford:The Cochrane Collaboration.Update Software,1998(4)
7[4]Sutherland L,Roth D,Beck P et al.The use of oral 5-aminosalicylic acid in the induction of maintenance of remission in ulcerative colitis.In:The Cochrane Library(database on disk and CD-RON).Oxford:The Cochrane Collaboration.Update Software,1998,(4)
8[5]Kruis W,Brandes JW,Schreiber S,et al.Olsalaxine versus mesalazine in the treatment of mild to moderate ulcerative colitis.Aliment Pharmacol Ther,1998,12(8):7607-15
9[6]Stoa-Birketvedt G,Florholmen J.The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.Aliment Pharmacol Ther,1999,13(3):357-61
